T2C2 Capital

T2C2 Capital (Technology, Transfer, Commercialisation, Capital) is a venture capital and private equity firm investing in healthcare, information technology, business products, and services sectors that is headquartered in Montreal, Quebec and was founded in 2003.

As of December 2019), T2C2 Capital has made 23 investments, has 1 company in its portfolio, and has made 12 exits. Notable investments made by T2C2 Capital include: Cytochroma, Aegera Therapeutics, Chronogen, LatroQuest, Cytheris, TransPharma Medical, BioAxone Therepautic, Enobia pharma, Topigen Pharmaceuticals, Quazal Technologies, and Interomex BioPharmaceuticals.